drugset / Trial / NCT04042324

A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

NCT04042324

Phase 1/2 Completed 12 enrolled Rockwell Medical Technologies, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study will investigate the effect of co-administration of Triferic and heparin on the ability to maintain circuit anti-coagulation and iron delivery when compared to control conditions when each treatment is administered via separate routes.

Timeline

Start
2019-09-30
Primary completion
2020-01-16
Completion
2020-01-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Triferic Other / unclassified 6.75 mg Intravenous
Background Heparin Other / unclassified Intravenous